gds clinicalzest limited
gds clinicalzest limited Company Information
Company Number
08659841
Website
-Registered Address
10 monastery avenue, dover, CT16 1AB
Industry
Other information service activities n.e.c.
Telephone
-
Next Accounts Due
May 2025
Group Structure
View All
Directors
Gwyn D'Souza10 Years
Shareholders
gwyn ann ophilda d'souza 100%
gds clinicalzest limited Estimated Valuation
Pomanda estimates the enterprise value of GDS CLINICALZEST LIMITED at £2.6m based on a Turnover of £2.6m and 0.99x industry multiple (adjusted for size and gross margin).
gds clinicalzest limited Estimated Valuation
Pomanda estimates the enterprise value of GDS CLINICALZEST LIMITED at £227.1k based on an EBITDA of £48.5k and a 4.68x industry multiple (adjusted for size and gross margin).
gds clinicalzest limited Estimated Valuation
Pomanda estimates the enterprise value of GDS CLINICALZEST LIMITED at £3.1m based on Net Assets of £1.2m and 2.48x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Gds Clinicalzest Limited Overview
Gds Clinicalzest Limited is a live company located in dover, CT16 1AB with a Companies House number of 08659841. It operates in the other information service activities n.e.c. sector, SIC Code 63990. Founded in August 2013, it's largest shareholder is gwyn ann ophilda d'souza with a 100% stake. Gds Clinicalzest Limited is a established, small sized company, Pomanda has estimated its turnover at £2.6m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Gds Clinicalzest Limited Health Check
Pomanda's financial health check has awarded Gds Clinicalzest Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
4 Strong
1 Regular
5 Weak
Size
annual sales of £2.6m, make it larger than the average company (£824.4k)
- Gds Clinicalzest Limited
£824.4k - Industry AVG
Growth
3 year (CAGR) sales growth of 16%, show it is growing at a faster rate (7.1%)
- Gds Clinicalzest Limited
7.1% - Industry AVG
Production
with a gross margin of 38.1%, this company has a higher cost of product (72.2%)
- Gds Clinicalzest Limited
72.2% - Industry AVG
Profitability
an operating margin of 1.9% make it less profitable than the average company (7%)
- Gds Clinicalzest Limited
7% - Industry AVG
Employees
with 1 employees, this is below the industry average (18)
1 - Gds Clinicalzest Limited
18 - Industry AVG
Pay Structure
on an average salary of £29.7k, the company has an equivalent pay structure (£29.7k)
- Gds Clinicalzest Limited
£29.7k - Industry AVG
Efficiency
resulting in sales per employee of £2.6m, this is more efficient (£55.3k)
- Gds Clinicalzest Limited
£55.3k - Industry AVG
Debtor Days
it gets paid by customers after 176 days, this is later than average (30 days)
- Gds Clinicalzest Limited
30 days - Industry AVG
Creditor Days
its suppliers are paid after 3 days, this is quicker than average (35 days)
- Gds Clinicalzest Limited
35 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Gds Clinicalzest Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Gds Clinicalzest Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 1.4%, this is a lower level of debt than the average (26.4%)
1.4% - Gds Clinicalzest Limited
26.4% - Industry AVG
GDS CLINICALZEST LIMITED financials
Gds Clinicalzest Limited's latest turnover from August 2023 is estimated at £2.6 million and the company has net assets of £1.2 million. According to their latest financial statements, Gds Clinicalzest Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Aug 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||||
| Other Income Or Grants | ||||||||||
| Cost Of Sales | ||||||||||
| Gross Profit | ||||||||||
| Admin Expenses | ||||||||||
| Operating Profit | ||||||||||
| Interest Payable | ||||||||||
| Interest Receivable | ||||||||||
| Pre-Tax Profit | ||||||||||
| Tax | ||||||||||
| Profit After Tax | ||||||||||
| Dividends Paid | ||||||||||
| Retained Profit | ||||||||||
| Employee Costs | ||||||||||
| Number Of Employees | 1 | 1 | 1 | 1 | 1 | 1 | ||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Aug 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 583 | 777 | 1,036 | 174 | 218 | 272 | 340 | 425 | 531 | 664 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 583 | 777 | 1,036 | 174 | 218 | 272 | 340 | 425 | 531 | 664 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 1,255,510 | 1,255,900 | 1,068,685 | 885,267 | 703,837 | 558,367 | 376,010 | 212,991 | 9 | 205 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 114,029 | 75,653 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 1,255,510 | 1,255,900 | 1,068,685 | 885,267 | 703,837 | 558,367 | 376,010 | 212,991 | 114,038 | 75,858 |
| total assets | 1,256,093 | 1,256,677 | 1,069,721 | 885,441 | 704,055 | 558,639 | 376,350 | 213,416 | 114,569 | 76,522 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 17,061 | 53,283 | 51,198 | 42,756 | 38,367 | 43,835 | 39,515 | 26,393 | 15,157 | 19,184 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 17,061 | 53,283 | 51,198 | 42,756 | 38,367 | 43,835 | 39,515 | 26,393 | 15,157 | 19,184 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 50 | 800 | 800 | 1,195 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 1,195 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 50 | 800 | 800 | 1,195 | 1,195 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 17,111 | 54,083 | 51,998 | 43,951 | 39,562 | 43,835 | 39,515 | 26,393 | 15,157 | 19,184 |
| net assets | 1,238,982 | 1,202,594 | 1,017,723 | 841,490 | 664,493 | 514,804 | 336,835 | 187,023 | 99,412 | 57,338 |
| total shareholders funds | 1,238,982 | 1,202,594 | 1,017,723 | 841,490 | 664,493 | 514,804 | 336,835 | 187,023 | 99,412 | 57,338 |
| Aug 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Operating Profit | ||||||||||
| Depreciation | 133 | 166 | ||||||||
| Amortisation | 0 | 0 | ||||||||
| Tax | ||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -390 | 187,215 | 183,418 | 181,430 | 145,470 | 182,357 | 163,019 | 212,982 | -196 | 205 |
| Creditors | -36,222 | 2,085 | 8,442 | 4,389 | -5,468 | 4,320 | 13,122 | 11,236 | -4,027 | 19,184 |
| Accruals and Deferred Income | -750 | 0 | -395 | 1,195 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||||
| Investing Activities | ||||||||||
| capital expenditure | ||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||
| Financing Activities | ||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | -1,195 | 1,195 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||
| interest | ||||||||||
| cash flow from financing | ||||||||||
| cash and cash equivalents | ||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -114,029 | 38,376 | 75,653 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -114,029 | 38,376 | 75,653 |
gds clinicalzest limited Credit Report and Business Information
Gds Clinicalzest Limited Competitor Analysis
Perform a competitor analysis for gds clinicalzest limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
gds clinicalzest limited Ownership
GDS CLINICALZEST LIMITED group structure
Gds Clinicalzest Limited has no subsidiary companies.
Ultimate parent company
GDS CLINICALZEST LIMITED
08659841
gds clinicalzest limited directors
Gds Clinicalzest Limited currently has 1 director, Dr Gwyn D'Souza serving since Aug 2013.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Gwyn D'Souza | United Kingdom | 60 years | Aug 2013 | - | Director |
P&L
August 2023turnover
2.6m
+16%
operating profit
48.5k
0%
gross margin
38.1%
-0.9%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
August 2023net assets
1.2m
+0.03%
total assets
1.3m
0%
cash
0
0%
net assets
Total assets minus all liabilities
gds clinicalzest limited company details
company number
08659841
Type
Private limited with Share Capital
industry
63990 - Other information service activities n.e.c.
incorporation date
August 2013
age
11
accounts
Micro-Entity Accounts
ultimate parent company
previous names
N/A
incorporated
UK
address
10 monastery avenue, dover, CT16 1AB
last accounts submitted
August 2023
gds clinicalzest limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to gds clinicalzest limited.
gds clinicalzest limited Companies House Filings - See Documents
| date | description | view/download |
|---|
